Lefer A M, Papanicolaou G
Methods Find Exp Clin Pharmacol. 1985 Feb;7(2):59-63.
The effects of two new calcium entry blockers, anipamil and ronipamil, were studied during 150 min of normoxic or hypoxic perfusion in isolated perfused cat livers. Hypoxic livers in which the vehicle for these inhibitors (i.e., ethanol) was injected intravenously prior to isolation of the liver, exhibited significantly higher increases in perfusion pressure, perfusate lactate dehydrogenase and cathepsin D activities, compared to control normoxic perfused livers. In contrast, the livers isolated from cats pretreated with calcium entry blocker anipamil and subsequently perfused under hypoxic conditions showed no significant difference in any of these variables from the control normoxic perfused livers. Ronipamil given intravenously 30 minutes prior to isolation also significantly protected the liver during hypoxia. The protection afforded by anipamil and ronipamil appears to be related to their inhibition of Ca++ influx which has been linked to cell death in hepatocytes.
在离体灌注猫肝脏的常氧或低氧灌注150分钟期间,研究了两种新型钙通道阻滞剂阿尼帕米和罗尼帕米的作用。在肝脏离体前静脉注射这些抑制剂的载体(即乙醇)的低氧肝脏,与对照常氧灌注肝脏相比,灌注压、灌注液乳酸脱氢酶和组织蛋白酶D活性显著升高。相比之下,从用钙通道阻滞剂阿尼帕米预处理的猫分离的肝脏,随后在低氧条件下灌注,在这些变量中的任何一个与对照常氧灌注肝脏相比均无显著差异。在肝脏离体前30分钟静脉注射罗尼帕米在低氧期间也显著保护了肝脏。阿尼帕米和罗尼帕米提供的保护作用似乎与其对Ca++内流的抑制有关,Ca++内流与肝细胞死亡有关。